Melanie Valenti

Also affiliated with Discovery Centre, Institute of Cancer Research, Cancer Clinic

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma”.

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

Journal of Clinical Investigation(2020)10.1172/jci134132

N/A

0DataRank · unranked

71 citations

Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert +38 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more